San Diego, CA, United States of America

Blake Alan Rowe


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Blake Alan Rowe

Introduction

Blake Alan Rowe is a notable inventor based in San Diego, CA. He has made significant contributions to the field of neuroscience, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents, his work focuses on innovative methods for identifying effective compounds for treatment.

Latest Patents

Rowe's latest patents include methods for identifying compounds effective for treating neurodegenerative diseases. These methods involve determining the relative amount of .alpha.-sAPP and the ratio of .alpha.-sAPP to total sAPP in body fluids, tissues, or cell culture. Another significant patent involves peptide and peptide analog protease inhibitors, which provide methods for treating disorders characterized by the cerebral deposition of amyloid. The compounds described in this patent include specific formulas that target various chemical structures.

Career Highlights

Blake Alan Rowe is currently associated with Sibia Neurosciences, Inc., where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic strategies for complex neurological conditions.

Collaborations

Rowe collaborates with esteemed colleagues, including Robert Steven Siegel and Steven Lee Wagner. Their combined expertise enhances the research efforts at Sibia Neurosciences, Inc.

Conclusion

Blake Alan Rowe's contributions to neuroscience through his patents and collaborative efforts highlight his commitment to advancing treatments for neurodegenerative diseases. His innovative approaches continue to pave the way for future discoveries in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…